Aposta · Oct 27, 2026

Apelin and GDF-15 in sarcopenia in adults and older adults: a systematic review with exploratory meta-analysis

By PAULA MDS, dos Santos RP, dos Santos LL et al.

Sarcopenia encompasses changes in strength, muscle mass, and physical performance, whose investigation can be enriched by circulating biomarkers. This study synthesized the associations of apelin and growth differentiation factor 15 (GDF-15) with sarcopenia and its components in adults and older adults. The review included 51 publications identified in nine sources: PubMed/MEDLINE, Scopus, Embase, Web of Science, Cochrane Library, LILACS, Europe PMC, OpenAlex, and DOAJ. The documented counts totaled 897 records, with removals, exclusions, and inclusions consolidated into a single flowchart. The studies were organized by biomarker, population, diagnostic definition, exposure unit, and outcome. The exploratory meta-analysis of three adjusted odds ratios for elevated GDF-15 yielded OR 1.98, with IC 95% of 0.98-4.02 using modified Hartung-Knapp and I2 = 0%. The subset of two studies with a clinical diagnosis showed OR 1.98 and IC 95% of 0.19-21.11. The conservative intervals include the absence of an association. The narrative synthesis brings together longitudinal evidence, Brazilian data, exercise, and rehabilitation; the associations of apelin were presented in their respective units. The review integrates evidence on muscle health and contributes to investigating biomarkers as information complementary to clinical and functional assessment.

doi.org/10.23900/ra.v24i123.071Open accessBiomarkers

AgingResearch.News